- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharm Exec Podcast Survey!
Hello all Pharm Exec podcasters! Thank you for taking the time to review our podcast survey. As you know, the podcast is about to start it’s 3rd year-and we’re really excited! We want to continue to bring you the latest and best guests this year to discuss business, strategy, R&D, and more in the pharma and biopharma industry.
Please click on the link below to complete a quick, 5-minute survey where we delve into how you listen to our episodes and what you’d most like to hear in 2020. The survey will close on November 8th, 2019.
Thank you again for your time, and we look forward to sharing more customized content in the future.
Complete the survey here!
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
